Outdated EP data doesn’t reflect real patients. Founded in 2019, HRCRS turns real-world data into actionable insights—powering smarter decisions, faster innovation, and better outcomes across the product lifecycle.
Join our learning ecosystem.
DM to connect.
Real-world REAL-AF Registry data showed a favorable early safety profile for pulsed field ablation (PFA) with VLCC, including in persistent AF and complex procedures, with very low complication rates and no catheter-attributed adverse events.
📖 Read: https://t.co/Y8NGjnFMtR
New REAL-AF Registry data highlights important sex-based differences in AF ablation outcomes, with women showing higher long-term recurrence and hospitalization rates despite more extensive procedures.
📖 Read: https://t.co/7bvOMMNXy6
3PH co-founder & CMO @josoriomd , MD will be at @Med_Tech_World (North America 2026).
He’ll share how startups can align clinical + regulatory + go-to-market early to avoid delays and reach adoption faster.
Attending #MedTechWorldNorthAmerica2026? DM us!
What happens when great ideas come together in one place?
#HRS26 in Chicago brought the EP community forward.
We leave energized and ready for what’s next!
We look forward to seeing you at #HRS2026!
Tomorrow, Christopher Porterfield will present the first insights from VariSure, highlighting initial safety data on the Variable Loop Circular Catheter.
Explore the details below:
HRCRS runs on a network of 270+ physicians and partners, so evidence is collaborative and measurable.
We generate real-world data through dynamic registries and share learnings via publications, abstracts, and education.
Want to plug in? DM us.
New REAL-AF registry data show Vein of Marshall ethanol ablation is safe and associated with lower arrhythmia recurrence in persistent AF.
Study led by Drs. @Nicky_P_MD and @DanielAlyeshmer.
Published in a @hrs_journal.
🔗 Link in comments:
Heading to #CRT2026? Connect with Maggi Savo, Director of Business Development at HRCRS!
We design smarter Real-World Evidence studies with end-to-end CRO execution and deep cardiovascular expertise.
@CRT_meeting
Back from a remarkable AF Symposium 2026 in Boston, and we are more energized than ever by the opportunity ahead!
We’re grateful for the partners, innovators, and clinical leaders who spent time with us this week, and we’re excited to turn those conversations into action.
As promised, clinical data and real-world experience were front and center at #AFSymposium2026!
Thank you to @seiiwaiEPmd for a compelling Spotlight Session and to @SaumilOzaMD for highlighting important data from the VITAL-EP registry. We appreciate your leadership and collaboration in moving the field forward in a meaningful way.
And, thank you to everyone who stopped by the Vektor booth to connect with our team. The conversations and questions were energizing and insightful.
Next up: Western AFib later this month and HRS 2026 in April.
#WAFIB2026 #HRS2026 #electrophysiology #vMap
#News: We’re kicking off #AFSymposium2026 with exciting news — new results from the multicenter VITAL-EP Registry that highlight how #vMap can support fast, low-fluoroscopy AF ablation workflows across paroxysmal, persistent, and longstanding persistent AF.
Full details in the press release: https://t.co/ySnraJP0rP
Early findings show:
☑️Median PVI+ procedure time: ~70 minutes
☑️Median fluoroscopy time: 0 minutes
☑️Median mapping time: <10 minutes
🔦 Spotlight Session | TODAY at 8:30 AM | AF Symposium: Dr. @seiiwaiEPmd will share his clinical experience using non-invasive mapping of AF drivers to guide more comprehensive ablation strategies, highlighting how patient-specific atrial activation maps can inform decisions beyond PVI.
📍 Visit us at Booth 208 to learn more about the VITAL-EP findings and what’s new with vMap. We’re showcasing new atrial flutter capabilities that expand vMap’s non-invasive analysis to distinguish typical and atypical atrial flutter using a standard 12-lead ECG, enabling more comprehensive arrhythmia evaluation on a single platform.
#eplab #electrophysiology #cardiology
The VITAL EP Registry explores the use of vMap for AF ablation.
New data will be shared at the 2026 AF Symposium.
📍Omni Boston at the Seaport
🗓️ February 5-7
We’re proud to announce Keith Hebert as the new COO of HRCRS, a 3PH Alliance Company.
With 27 years in clinical research, Keith brings a strong commitment to operational excellence and purpose-driven impact.
A new chapter begins! Congratulations, Keith!
The VARISURE Retrospective Survey offers a first look, presented at the 31 st AF Symposium.
Backed by real-world results, this data helps us better understand the role of innovation in atrial fibrillation care.
A closer look at zero-fluoroscopy workflows and the safety of circular catheters in AF ablation. That’s what the REAL AF Registry brings to this year’s AF Symposium. Two important studies:
📍AF Symposium 2026
🗓️February 5-7 | Boston
The DISRUPT AF Registry will be featured at #AFSymposium2026, and so will new insights on pulsed field ablation using the pentaspline catheter.
From procedural safety to real-world workflows and recurrence, these studies show the growing value of clinical evidence in innovation.